Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study-Reference-Cited by-同舟云学术

Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study

Published:2021-12 Issue:4 Volume:20 Page:e253-e262
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Lai Eleonora^ORCID,Puzzoni Marco^ORCID,Ziranu Pina^ORCID,Cremolini Chiara,Lonardi Sara^ORCID,Banzi Maria,Mariani Stefano,Liscia Nicole,Cinieri Saverio,Dettori Manuela,Mencoboni Manlio,Nappo Floriana^ORCID,Piacentini Giulia,Labianca Roberto,Zucchelli Gemma,Boccaccino Alessandra^ORCID,Conca Veronica^ORCID,Pusceddu Valeria,Zaniboni Alberto,Scartozzi Mario

Funder

Bayer

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference30 articles.

1. Molecular-biology-driven treatment for metastatic colorectal cancer;Lai;Cancers (Basel),2020

2. Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients;Puzzoni;Future Oncol,2020

3. Is there an optimal choice in refractory colorectal cancer? A network meta-analysis;Casadei-Gardini;Clin Colorectal Cancer,2020

4. The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab;Demurtas;Br J Cancer,2017

5. Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link?;Pani;Eur J Endocrinol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence;Future Oncology;2024-06-11

2. Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging;Cancers;2024-03-30